How New Vaccine Guidelines May Put Older Adults At Risk - Howard Gleckman
How a CDC advisory panel's vaccine recommendations may put vulnerable older adults at risk for sickness or even death| Howard Gleckman
How a CDC advisory panel's vaccine recommendations may put vulnerable older adults at risk for sickness or even death| Howard Gleckman
Three days before the ACIP’s meeting last week, Robert F. Kennedy Jr. appointed five new members to the ACIP, a process that usually takes months. The panel now has a total of 12 members. The new members will “bring diverse expertise that strengthens the committee and ensures it fulfills its mission with transparency, independence, and… The post RFK appointed five new members to ACIP appeared first on Drug Discovery and Development.| Drug Discovery and Development
Last Friday, the ACIP voted to recommend COVID vaccination “based on individual-based decision-making” for adults 65 and older. For individuals 6 months to 64 years old, the vaccine is recommended based on individual decision, “with an emphasis that the risk-benefit of vaccination is more favorable for individuals who are at an increased risk for severe… The post ACIP recommends COVID vaccine based on “individual decision making” appeared first on Drug Discovery and Development.| Drug Discovery and Development
The ACIP met this week to vote on recommendations for the MMRV, Hepatitis B and COVID vaccines. On Thursday, they voted to recommend separate MMR and varicella vaccines for children under four, instead of the combination MMRV vaccine. On Friday, they voted to table the Hepatitis B decision for another meeting. Also on Friday, the… The post ACIP voted to stop recommending MMRV vaccine for young children appeared first on Drug Discovery and Development.| Drug Discovery and Development
On Friday, Kevenue, the maker of Tylenol, saw its stocks drop more than 10% after the Wall Street Journal reported that Health and Human Services Secretary Robert F. Kennedy plans to release a federal report connecting prenatal use of Tylenol to autism. As Kennedy and his appointed vaccine panel continue to erode vaccine recommendations, many… The post Vaccine makers’ stocks continue to spiral as the segment faces fresh pressures appeared first on Drug Discovery and Development.| Drug Discovery and Development
Inspired by the Spirit-filled testimony of a residential school survivor, Primate Shane Parker calls for Survivors’ flags to be raised in every Anglican parish in Canada as visible signs of recognition, respect and hope.| The Anglican Church of Canada
We’ve all become entirely too familiar with ACIP, the CDC panel that discusses and recommends vaccination schedules across a wide swath of vaccines. The method by which ACIP became part of th…| Techdirt
The newly appointed ACIP committee met and discussed flu and RSV and thimerosal| Voices For Vaccines
Secretary RFK Jr's drastic actions against ACIP have raised concerns among medical professionals and Congressmembers alike.| VAXOPEDIA
The FDA has approved Novavax's Nuvaxovid, a non-mRNA COVID vaccine aimed at adults 65 and high-risk individuals aged 12-64. Although the approval is limited, many people qualify due to underlying conditions. Nuvaxovid offers an effective alternative, with simpler storage and fewer side effects compared to other vaccines. The post The Novavax COVID Vaccine Has Been Approved appeared first on VAXOPEDIA.| VAXOPEDIA
Vinay Prasad is poised to become the director of CBER at the FDA, a role crucial for vaccine approval. His past statements show opposition to COVID vaccines for children, concerns over U.S. vaccination rates, and belief in loosening manufacturer liability. Critics argue his views may exacerbate vaccine hesitancy, undermining public health initiatives. The post What Has Vinay Prasad Said About Vaccines? appeared first on VAXOPEDIA.| VAXOPEDIA
